A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans
1998 ◽
Vol 9
(6)
◽
pp. 517-524
◽
1998 ◽
Vol 28
(5)
◽
pp. 229-235
◽
2001 ◽
Vol 85
(06)
◽
pp. 979-985
◽
1996 ◽
Vol 7
(4)
◽
pp. 477-483
◽
1998 ◽
Vol 91
(4)
◽
pp. 177-181
◽
2002 ◽
Vol 13
(4)
◽
pp. 289-296
◽
1991 ◽
Vol 2
(5)
◽
pp. 629-636
◽
2000 ◽
Vol 100
(5)
◽
pp. 413-417
◽
1999 ◽
Vol 107
(4)
◽
pp. 756-762
◽